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Oral Presentations 19suggests that in the genetic absence of CD41 T cells, a CD8 regu-
latory population may emerge. In total, our observations support
the notion that functioning host Tregs initially occupy a niche in
the transplant recipient permitting lymphopenic expansion and an
extended period of contribution to this compartment. Notably,
this contribution reflected much greater levels than that by other
lymphoid cell populations. Overall, the findings imply that host
Treg cells may be important to consider with respect to eliciting
anti-tumor and vaccination responses in recipients during the early
period post-hematopoietic cell transplantation.45
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LIN AND COLLAGEN V IN PATIENTS WITH CHRONIC GRAFT VERSUS
HOST DISEASE
Pusic, I.1, Saini, D.2, Pavletic, S.Z.3, Hakim, F.3, Shannon, W.D.1,
Mohanakumar, T.2,4, DiPersio, J.F.1. 1Washington University School
of Medicine, St. Louis, MO; 2Washington University School of Medicine,
St. Louis, MO; 3National Institutes of Health, Bethesda, MD; 4Wash-
ington University School of Medicine, St. Louis, MO.
Background:ChronicGraft vs.HostDisease (cGVHD) is amul-
tisystem alloimmune and autoimmune disorder characterized by
production of antibodies, immune dysregulation and impaired or-
gan function resembling autoimmune diseases. NIH Consensus
Criteria for cGVHD (Filipovich et al, BBMT 11:945, 2005) defines
bronchiolitis obliterans (BO) diagnosed clinically as a distinctive
feature (seen in cGVHDbut insufficient alone to establish the diag-
nosis) and BO diagnosed by lung biopsy as a diagnostic feature of
cGVHD (sufficient to establish the diagnosis). Chronic rejection
following human lung transplantation is strongly associated with
development of alloimmune response to donor mismatched HLA
antigens. Recent studies in our laboratory and others have shown
a strong correlation between development of autoimmunity to self
antigens K-alpha-1 tubulin and collagen V with tissue damage
and immunopathogenesis of chronic rejection characterized by
BO. In this study, we analyzed the presence of antibodies to self-an-
tigens K-alpha-1 tubulin and collagen V in patients with cGVHD.
Methods: Serum samples from patients with cGVHD were ana-
lyzed for antibodies which bind to human recombinant purified
K-alpha-1 tubulin (1 mcg/ml) and collagen V using ELISA assays.
Analysis of variance was used to compare the means of different
groups with p\0.05 as an indicator of strong association. Results:
Study includes 21 patients with cGVHDdeveloping after allogeneic
transplantation for hematological malignancies and 10 normal con-
trols. 11 patients with cGVHD had lung involvement by NIH Cri-
teria with minimal lung score of 2. Levels of K-alpha-1 tubulin
antibodies were higher in patients with lung cGVHD when com-
pared to patients without lung involvement or normal controls (p
5 0.027). Levels of Collagen V antibodies were higher in patients
with lung cGVHD when compared to normal controls (p 5
0.025) but not when compared to patients without cGVHD of the
lung. 64% of patients with lung involvement by cGVHD developed
antibodies to both antigens and 82% had antibodies to at least one.
Conclusion: In this preliminary analysis development of antibodies
to K-alpha-1 tubulin and to collagen V appears to be highly associ-
ated with cGVHD and the highest titer autoantibodies are seen in
those patients with lung involvement. Studies are underway to de-
fine the kinetics of these antibodies after transplantation and their
incidence and titers in allogeneic stem cell recipients without clin-
ical signs of cGVHD.46
ANDROGEN WITHDRAWAL MODULATES THYMOPOIESIS BY INDUCING
THYMIC EPITHELIAL CELL PROLIFERATION AND INCREASING PRECUR-
SOR NICHE
Williams, K.M., Lucas, P.J., Bare, C.V., Wang, J., Chu, Y.-W.,
Gress, R.E. National Institutes of Health/National Cancer Institute,
Bethesda, MD.Impaired thymopoiesis contributes to immune deficiency follow-
ing allogeneic stem cell transplantation. Emerging clinical literature
suggests that graft-versus-host disease may be exacerbated and
graft-versus-leukemia effect compromised in the setting of thymic
insufficiency. Data have demonstrated that the thymus is damaged
following the transplant preparative regimen, with a depletion of
UEA1 thymic epithelial cells. We show that castration of male
mice results in thymic renewal, as demonstrated by increased thy-
mocyte number, intrathymic T cell receptor excision circles, and
the number of early thymic progenitors (ETP: Lin- CD25- c-kit
hi CD44 hi) as early as eight days post-castration. These observa-
tions suggested a mechanism of enhanced thymopoieis that occurs
through increased immigration of thymocyte precursors. Studies
with adoptively transferred congenic marrow progenitors confirm
that enhanced ETP immigration is an early event following andro-
gen withdrawal. Data also demonstrate a significant increase in
UEA1 thymic epithelial cell proliferation by BRDU1 incorpora-
tion in the initial time frame following castration, implicating thy-
mic epithelial cell proliferation in this thymic expansion, and
suggesting that there may be an increase in thymic niche regulating
ETP uptake.We have further identified an increase in a stromal de-
rived protein important for ETP uptake by Western blot in total
thymus lysates consistent with a mechanism of an increased ETP
niche. Preliminary data also suggest that the mRNA encoding this
protein is increased in sorted thymic epithelial subsets, with the
greatest increase in the UEA1 medullary TEC cells, implicating
these medullary epithelial cells in ETP entry. Taken together, we
show that androgen withdrawal leads to UEA1medullary cell pro-
liferation with augmented ETP niche and entry. Thus, we identify
ETP uptake as a critical and dynamically controlled point of thymic
regulation.LATE EFFECTS/QUALITY OF LIFE47
PROSPECTIVE NEUROCOGNITIVE FUNCTION AND RISK FACTORS AT 5
YEARS AFTER ALLOGENEIC HEMATOPOIETIC CELL TRANSPLANTATION
(HCT) FOR HEMATOLOGIC MALIGNANCIES, COMPARED WITH CON-
TROLS AT 5 YEARS
Syrjala, K.L.1,2, Artherholt, S.B.1, Kurland, B.F.1, Langer, S.L.1,2,
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Investigators have documented significant cognitive decline after
high dose treatment followed by allogeneic HCT. We have deter-
mined that partial recovery occurs by 1 year, but deficits remain
in verbal capacity and motor skills. Our current aims were to deter-
mine the extent of long-term cognitive dysfunction, and risk factors
for deficits at 5 years.We hypothesized improvement between 1 and
5 years, and that risk factors would include type of treatment before
transplant, and duration of immunosuppressant medications. A to-
tal of 142 adults completed neuropsychological tests for verbal
memory (Hopkins Verbal Learning Test; HVLT), verbal fluency
(Controlled Oral Word Association Test; COWAT), information
processing (Digit Symbol and Trail Making B; Trails B) and motor
dexterity and speed (Grooved Pegboard), among other tests. Survi-
vors were re-tested after 80 days, and 1 and 5 years post-transplant.
A neuropsychologist traveled to test each of N5 66 5 year survivors
and case-matched controls in person. Generalized estimating equa-
tions indicated significant changes over time frompretransplant to 5
years in all tests except memory (P\ .0001; memory P 5 .17). Be-
tween 1 and 5 years, verbal fluency continued to improve (P5 .001),
as did information processing (P\ .01); but motor dexterity and,
memory did not (P . .65), remaining below controls (P\ .0001
motor dexterity, P 5 .060 verbal memory). Table 1 indicates the
percent impaired (t score # 40) at 5 years. The only identified
risk factor for poorer verbal memory at 5 years was history of intra-
thecal chemotherapy or cranial irradiation (95% Confidence Inter-
val (CI) 0.71, 15.13, P 5 .03). Risk factors for impaired motor
dexterity and speed at 5 years included immunosuppression longer
